Profile
J.
Nick Riehle served as the Chief Financial Officer and VP-Administration at HAHT Commerce, Inc. from 1996 to 2003.
He then worked as the Chief Financial Officer and VP-Administration at Chelsea Therapeutics International Ltd.
from 2004 to 2014.
In 2017, he briefly served as the Chief Financial Officer at Athenex, Inc. before leaving.
Riehle received his undergraduate degree from McGill University and his MBA from York University.
Former positions of J. Nick Riehle
| Companies | Position | End |
|---|---|---|
| ATHENEXPAR | Director of Finance/CFO | 2017-12-30 |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Director of Finance/CFO | 2014-06-22 |
| Ivory Capital Corp. | Director of Finance/CFO | 2005-08-01 |
HAHT Commerce, Inc.
 HAHT Commerce, Inc. Packaged SoftwareTechnology Services HAHT Commerce Inc. is a provider of Demand Chain Management solutions, essential software applications, used to automate, integrate and optimize business processes, transactions and information exchange between manufacturers, channel partners and their customers. In real-time. With out-of-the-box ERP integration | Director of Finance/CFO | 2003-05-31 |
Training of J. Nick Riehle
| McGill University | Undergraduate Degree |
| York University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
| Ivory Capital Corp. | Finance |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
HAHT Commerce, Inc.
HAHT Commerce, Inc. Packaged SoftwareTechnology Services HAHT Commerce Inc. is a provider of Demand Chain Management solutions, essential software applications, used to automate, integrate and optimize business processes, transactions and information exchange between manufacturers, channel partners and their customers. In real-time. With out-of-the-box ERP integration | Technology Services |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Stock Market
- Insiders
- J. Nick Riehle
